StemCell Therapy

GETTY

Opticians are urging British people to beware the harmful effects of too much sun exposure on their eyes.

This is because its ultraviolet (UV) rays can cause macular damage.

The most common form is age-related macular degeneration (AMD).

It's the leading cause of sight loss in the developed world.

GETTY

While smoking, a poor diet and genetics can increase risk of macular damage, sun exposure also plays a part.

While smoking, a poor diet and genetics can increase risk, sun exposure also plays a part.

To coincide with this week's 2017 Macular Week, Specsavers are aiming to highlight the importance of protecting your eyes during sunny weather.

This is particularly important given that further heatwaves are expected this summer.

AMD occurs when a persons retinal cells die off and are not regenerated, leading to visual impairment and in some cases, blindness.

SWNS.com

1 of 40

Miss Devon, Becky Wright (17) enjoys the sunshine and hot weather at the Paignton beach in Devon. June 20, 2017

GETTY

However, its effects can be avoided.

Dr Nigel Best, Specsavers clinical spokesperson, said: "AMD affects more than 600,000 people across the UK. Its a staggering amount - especially when you consider the fact that just a few lifestyle changes can improve your chances of avoiding the condition.

"What a lot of people dont realise is that UV rays can be as harmful to your eyes as they are to your skin, therefore its crucial that people ensure they are wearing sunglasses or UV blocking contact lenses throughout the summer months to protect against the harmful exposure.

"Look for sunglasses that meet the European Safety standards, as well as at least 80% light reduction - that way you know that your exposure to UV light is significantly reduced."

GETTY

Sally Harvey, chief executive of the Royal National Institute of Blind People (RNIB), said: "We know that almost half of all cases of sight loss are preventable, and this is why RNIB recommends people protect their eyes from the sun this summer by wearing their sunglasses."

Symptoms of AMD include finding reading increasingly difficult, colours less vibrant and people's faces difficult to recognise.

According to the NHS, it's predicted almost 700,000 people will have late-stage AMD in the UK by 2020.

There's no cure, but there is evidence to suggest that a diet rich in green leafy vegetables can help slow its progression.

Go here to see the original:
UK heatwave warning: Too much sun exposure can cause BLINDNESS - Express.co.uk

Ironic that on the subject of capital punishment this editorial demonstrates some of the blindness. While the penal system keeps Mr. Rodriguez on death row and attorneys currently engaged in evidentiary hearings to uncover improprieties of the 2006 trial that led to the sentencing, the writers seem to give more attention to the cost to taxpayers than to examining the inherent injustice of capital punishment.

If we acknowledge that God is the creator of all life and that God is love and never withdraws that love from the people God has created with worth and dignity, that means that Mr. Rodriguez and other "degenerates"(words from the editorial) like him continue to be loved by God.

In this case, a horrible crime was committed and many innocent people suffer today because of it, especially the families of Dru Sjodin and Mr. Rodriguez. Perpetrators must take responsibility for their actions, and in the case of homicide, accept a rigorous punishment imposed by the justice system. And in the instances of homicide by capital punishment, who holds the United States culpable?

The editorial concludes with the question: "What good comes from keeping Rodriguez alive?"

An immediate good among others, would be to see a decrease in the number of murders committed by the United States in the name of us, the citizens.

Sister Pat Murphy CSJ

Crookston

See more here:
Letter: Recent opinion shows blindness by Herald | Grand Forks ... - Grand Forks Herald

Newswise Industrial biotechnology scientists, educators, entrepreneurs and executives from around the globe will be convening on the University of California San Diego campus this summer to explore the latest advances and world-changing innovations heating up the white-hot field of industrial biotechnology with workshops in microbial fermentation and metabolic engineering.

UC San Diego Extension will host its annual Industrial Biotechnology Workshops on Aug. 14 through 18. Participants can attend the whole program or attend the workshops on microbial fermentation or metabolic engineering separately.

Now in its fifth year, this widely acclaimed educational event creates an informal, intimate environment for robust exchange of knowledge and ideas among world-class academic instructors and leaders of cutting-edge companies of every size from startup to mature, said Hugo Villar, associate dean of Professional & Continuing Education for UC San Diego Extension.

Whether from California or China, biotechnology professionals attending these workshops will have a front-row seat to learn about current developments and advanced scientific skills being used to solve some the worlds most difficult problems, Villar said.

Microbial Fermentation

For the past four years, the workshop focused primarily on microbial fermentation, which is the transformation of feedstocks, such as plant sugars, into useful products, like fuels, chemicals, beer or antibiotics, by bacteria, yeast, fungi or algae.

The Microbial Fermentation Workshop will be held Aug. 16 to 18. Participants will be introduced to the fundamental knowledge and practical skills needed to design, develop, optimize, control, scale-up, analyze and troubleshoot fermentation processes.

As one of just a handful of programs in the world that provide in-depth, practically oriented coursework in microbial fermentation, it is expected to draw participants from Connecticut to Croatia.

While workshop participants should have some basic knowledge and experience in fermentation, everyone from scientists to biotech business executives to graduate students could benefit from the microbial fermentation workshop.

This years program features some of the brightest minds in the field, including:

Jeff Lievense, senior advisor of Bioengineering & Technology, Genomatica;

Rachel Dutton, assistant professor of Molecular Biology, UC San Diego;

Michael Japs, senior director of Process Technology, Genomatica;

Jon Hansen, principal of New Leaf Biotech;

Jason Ryder, vice president, Process R&D, Hampton Creek; and

Karen Fortmann, senior research scientist, White Labs.

Five interactive case studies, including production of microbes for cheese and beer, will allow attendees to practice what they learn, while the Fermentation Firing Line segment will offer a lively, open ended forum for posing questions to the instructional team on fermentation-related topics.

In addition, everyone in attendance can participate in a tour of the global headquarters of White Labs, which produces yeast for beer making, and attend a hosted reception in its craft beer tasting room.

Metabolic Engineering

A new segment on metabolic engineering, which will run Aug. 14-15, will also be offered.

Recently named as one of the top 10 emerging technologies by the World Economic Forum, metabolic engineering focuses on the design and development of equipment and processes for manufacturing products such as agriculture, food, animal feed and pharmaceuticals.

Instructors joining the interactive course with case studies throughout the curriculum include:

John Pierce, MIT lecturer and former scientist at multinational firms BP and DuPont;

Adam Feist, project scientist, UC San Diego;

Ben Griffin, senior director, Microbial and Enzyme Engineering, Synthetic Genomics;

Jeff Lievense, senior advisor, Genomatica;

Jim Mills, chief technology officer, BioAmber, Inc.;

Bernhard Palsson, principal investigator, UC San Diego; and

Kristy Salmon, head of research, BP.

Those who attend the Metabolic Engineering segment are also invited to participate in a tour of the global headquarters of White Labs, which produces yeast for beer making, and attend a hosted reception in its craft beer tasting room.

Those interested in finding out more about the upcoming workshops can visit http://extension.ucsd.edu/industrialbiotech , call (858) 534-9353 or email unexbio@ucsd.edu.

Read the original post:
Explore Innovations in Industrial Biotechnology at Upcoming Workshops - Newswise (press release)

Venture Capitalist Biogeneration Ventures has exceeded the target size of its life sciences fund BGV III through investments from the European Investment Banks InnovFin Equity Facility and the Dutch Venture Initiative II.

The third fund of the Dutch company now comprises 66m, 16 more than the BVG IIIs initial target size. Biogeneration did not provide figures about the exact financial contributions of its new investors but said that investments will focus on medtech, diagnostic and drug development companies in Germany and Benelux.

The new fund will build on the first two BGV funds which yielded some success for investors including a 1,55bn divestment of Dezima Pharma into Amgen and the 7bn exit of Acerta Pharma, the largest private exit in Europe in the biotech sector to date.

Four investments have already been made from BVG III into German immuno-oncology company Catalym, and Dutch companies Escalier Biosciences, Scenic Biotech and Varmx, working on autoimmune diseases, target discovery, and haematology, respectively.

Our third fund makes BGV amongst the largest life sciences funds dedicated to seed investments in Europe, said Edward van Wezel, Managing Partner. Over the last decade we have made over twenty investments in the European life sciences ecosystem. Weve observed an ever-increasing interest from pharma in acquiring innovations earlier. With this third closing we are significantly exceeding our target fund size and are delighted with the commitment of EIF and other new and existing investors in BGV III. We expect to reach the maximum fund size of EUR 75m before the end of 2017.

BGV operates as a joint venture with Forbion Capital Partners, providing access to the later stage perspective on early innovation and a global network of experts and pharma companies. The BGV team has broad experience in investment, life sciences, business development, and commercial operations. The team includes experienced biotech entrepreneurs as venture partners and advisors.

Read more:
66m Life Sciences Fund focused on Germany and Benelux ... - European Biotechnology

Our mission: providing reliable solutions for the bioprocess market that will enable an improved quality of life

Applikon Biotechnology is a world leader in developing and supplying advanced bioreactor systems from laboratory scale to production scale. We are the only company that can take a customer from the initial screening stage up to full-scale production using the same platform. This minimizes scale-up risks and guarantees the shortest time to market for our customers new product development.

Applikon is known for bringing new technologies to the market. These new technologies offer advantages in process efficiency for research and development as well as pilot plant and production scale processes.

As a focused medium sized company we live by our motto A Step Ahead to differentiate ourselves from other suppliers. Our focus on developing bioreactor systems only, allows us to produce state-of-the-art equipment. This has resulted in a steady growth to the top position of the worldwide laboratory bioreactor market. The basis for our new product development lies in our strong cooperation with leading international universities and institutes.

As a privately owned company our focus is not on short-term shareholders value but on building a healthy company by supplying the best product offering for our customers now and in the long-term future. This is the basis of many long-term relations with our clients all over the world.

All our efforts are focused on supplying the best solution for our clients in the biotech and pharmaceutical industry. Validation and documentation is a vital part of our development procedures and this is extended throughout our whole company.

Applikon Biotechnology is unique in the mini and micro bioreactor range. No other company can offer a complete solution on this very small scale. We develop systems on a small scale that generate results that can be scaled to production scale. At the moment there are thousands of Applikon bioreactors used in the world from small scale R&D up to full scale cGMP production.

Since we started in 1974 we have shown a healthy growth and profit. R&D is done in house in our headquarters in Delft, The Netherlands. Design and engineering is done in house but real manufacturing is outsourced. Final assembling is done in-house (in our manufacturing sites in Delft and Guangzhou) as well as the final testing and documentation. We have our own sales and service organizations in the USA (Foster City, California and Dover, New Jersey), the UK (Tewkesbury) and China (Guangzhou). We have well trained local distributors for sales and service in over 30 countries.

We are continuously executing strategic plans to grow the top-line and strengthen our financial performance. New and ongoing programs are exploring new markets, developing innovative products, improving service to customers, increasing efficiency, and reducing costs.

More:
Applikon Biotechnology - European Pharmaceutical Review

The National

Late diagnosis can lead to disability for UAE children with arthritis The National According to The National Institute of Arthritis and Musculoskeletal and Skin Diseases in US, the most common symptoms of juvenile arthritis are joint swelling, pain, and stiffness that does not go away. Usually it affects the knees, hands, and feet ...

Read the original:
Late diagnosis can lead to disability for UAE children with arthritis - The National

By Dr. Robert Ashley Published: June 27, 2017 5:00 AM CDT Updated: June 27, 2017 5:00 AM CDT

Dear Doctor: A friend suggested I try MSM crystals for arthritis. What are they, and do they work? If they do, where can I find them?

Dear Reader: Methylsulfonylmethane (MSM) is an organic sulfur-containing compound naturally found in plants such as Brussels sprouts, garlic, asparagus, kale, beans and wheat germ. It also can be found in horsetail, an herbal remedy. MSM, which has been touted as a treatment for arthritis, is related to a similar compound, dimethyl sulfoxide (DMSO), that has been shown to have anti-inflammatory properties.

MSM may have anti-inflammatory properties, as well, but different from those associated with aspirin or nonsteroidal anti-inflammatory agents (NSAIDs). Unlike DMSO, which is a liquid applied at room temperature, MSM is a white crystalline compound hence the reference to "crystals."

As for whether it works, let's look at the evidence. A 2011 study performed in Israel assessed its impact on 50 people with arthritis of the knee. Twenty-five patients took a placebo, while 25 took 1.125 grams of MSM three times per day for 12 weeks. At 12 weeks, symptoms had worsened by 14 percent in the placebo group, but had improved by 20 percent in the MSM group. Pain had increased by 9 percent in the placebo group, but had decreased by 21 percent in the MSM group. Note that in this 12-week study, users noted no side effects.

A 2006 study also assessed MSM's impact on people with arthritis of the knee, with 25 people receiving a placebo and the other 25 receiving a 3-gram dose of MSM twice a day. At 12 weeks, pain had decreased by 25 percent in the MSM group, and by 13 percent in the placebo group. The physical function of the knee also improved with the use of MSM, but stiffness improved only slightly as compared to the placebo. This higher dose of MSM was associated with the mild side effects of bloating and constipation. One interesting note: The study authors found no change in inflammatory markers with MSM.

Lastly, a 2004 study from India compared the use of MSM, the use of glucosamine, the use of a combination and the use of a placebo for arthritis of the knee. After 12 weeks, patients who took 500 milligrams of MSM three times a day reported a significant reduction in pain and swelling of the knee. This also was seen in the group who took glucosamine. Those who took the combination of both MSM and glucosamine reported an additive benefit in regard to pain and swelling.

Granted, these are small studies, but they do show a slight benefit from MSM, but even milder than from Tylenol or NSAIDs. In these studies, the medication was used every day for 12 weeks, so I would assume that you would have to take MSM daily for a long period to see the benefit.

One important caveat: We don't know if there are any long-term side effects with MSM. If you do try it, start with 500 to 1,000 milligrams three times per day. That dose can be found in any drug or vitamin store.

Dr. Robert Ashley is an internist and assistant professor of medicine at the University of California, Los Angeles. Send your questions to askthedoctors@mednet.ucla.edu, or write: Ask the Doctors, c/o Media Relations, UCLA Health, 924 Westwood Blvd., Suite 350, Los Angeles, CA, 90095. Owing to the volume of mail, personal replies cannot be provided.

Here is the original post:
Could organic compound help with arthritis pain? - NewsOK.com

It is a known way to relieve pain in people, and now the Roger Williams Park Zoo in Providence, Rhode Island, is one of the first in the country to try acupuncture on a giraffe.

A nearly 2,000 pound patient named Sukari suffers from arthritis. The life expectancy for the species is usually in the teens, but Sukari is 24-years-old and showing signs of aging.

When she started slowing down, the animal keepers and other veterinary professionals started various medical treatments before deciding to introduce acupuncture.

There was a lot of things we had to consider, Dr. Jeremy Goodman, the zoos executive director, said. Will the giraffe tolerate it? Would it be effective? Would the keepers be able to administer it and how safe would it be?

Officials brought in a certified veterinary medical acupuncturist who used to intern at the zoo to begin treatments in March.

She had a little bit of hesitation right at the first treatment, some of the tail flicking and swishing, said Dr. Diva Malinowski Green.

While she administers the acupuncture, the keepers feed Sukari as a way to distract her and give her positive reinforcement for standing still.

The treatment for the animal is similar to human acupuncture in that the goal is to relieve pain by hitting certain points that reduce inflammation and assist with blood flow. The needles are also the same, even though the animal patient is much bigger.

The points are very much the same across species; however, because this species is built a little bit differently, you have to adapt the points, Green said.

After 45 minutes and 14 needles focused on the area around her hips, Sukari is finished with the session. She receives the treatment every other week, and so far, those at the zoo believe it is working.

We think it really is keeping her arthritis at bay, Goodman said. We know eventually her time will come, but until that point, and we hope its not for a while, shes going to have a great life here.

Published 44 minutes ago

Read the original here:
Aging Providence Giraffe Receives Acupuncture for Arthritis - NBC Boston

SALT LAKE CITY (KUTV) Today on Fresh Living were talking about Stem Cell Therapy.

Dr. Steven Warren from Intermountain Health and Wellness joined the show to share information with Casey & Kari about what patients need to know:

Before a patient commits to having a stem cell injection the patient should:

1. That an MRI or CT of the joint has shown the destruction of the tissue and Stem cells are needed to repair the damaged tissue.

2. Confirm that they will be getting a certificate that verifies that the injection will contain, live viable stem cells and at least a cell count of 1 million for most joints in the body.

3. That the doctor has been thoroughly trained in joint injections using guided imaging injections. Such as a C-arm fluoroscopy or Ultrasound.

4. Ensure the procedure will be performed under a strict sterile environment. To reduce the risk of a joint infection.

Intermountain Health and Wellness has a deal for Fresh Living viewers: call in NOW for a consultation to find out what stem cells can do for YOU! First 25 callers will receive a FREE MRI with the procedure. phone (801) 981-8795

For more information, visit: IntermountainStemCells.com

Read the original post:
Stem Cell Procedures: Know Before You Buy - KUTV 2News

In early 2015, 33-year-old Chris Herron was declared legally blind, and was told he had an 80-percent chance of losing his sight entirely in three months. Now, hes almost fully recovered, and has launched an audiobook channel that helps scifi and fantasy authors... just like how they once helped him.

Herron is the founder of Tall Tale TV, a YouTube channel where he makes and releases audiobooks for burgeoning scifi and fantasy works. Before that, he spent almost a year wondering if he would be able to read books again after being diagnosed with diabetic retinopathy, the most common cause of blindness for working-age adults. Its where people with diabetes (Herrons had Type 1 since he was 7) suffer from leaks or bleeding behind the eyes if they dont keep their blood sugar low. He was told hed need surgery in both eyes, and he had a four in five chance of going blind.

[When I found out], I hyperventilated and they had to lay me down. It came as a major shock, I had never even considered the possibility of not being able to see, Herron told io9. I decided I was going to fight it, and I was going to come out the other side regardless what they told me the chances were.

He immediately set out to change his lifestyle losing 30 pounds in the first month from diet and any exercise he could do, which started as guided walks with his wife. He described his sight as like looking through a cloud of ink, which meant he had trouble with many basic tasks. He also lost the ability to read and didnt know how to read Braille. Given his lifelong love of fantasy and science fiction, and how they served as an emotional release during bouts of depression, this hit hard.

It was actually pretty devastating because I loved writing and I loved reading, Herron said. It was actually my wife who suggested I turn to audio books.

The first audiobooks he picked up were from Terry Pratchetts Disc World series, and Herron said they changed his life. Hed listened to audiobooks before, but it was in passing while commuting to work, so he was worried it wouldnt be the same. But Herron was amazed at how much he loved them, saying it gave the book[s] an entire new layer or dimension. Herron listened to them for several months, using them to help during a difficult time. Then, his sight started to return. Herron said it happened gradually so he didnt really notice, but one visit to a doctors office showed how far hed come and the odds hed beaten.

My doctor looked at my eyes and he personally was kind of floored... he told me, Your vision is back at about 80-percent, and youre going to be fine, Herron said. I was so happy I cried.

Since then, Herrons sight has improved to about 90-percent of what it was before the diagnosis. Hes able to read regular books again, as well as use a computer for longer than a minute or two. But, hes still obsessed with audiobooks. More so... hes making them now.

A couple of months ago, Herron started Tall Tale TV, in hopes he could expose scifi and fantasy writers to a diverse audience, and give readers (especially those who are visually impaired) a new way of experiencing their work. The site focuses on short stories and individual chapters, so people dont get overwhelmed when listening to them. Right now, Herron narrates all of them by himself in his spare time (he also has a full-time job), but is looking to expand with more books and voice actors in the future.

You can check out Tall Tale TV here, with a new audiobook chapter expected to go up this week. Its worth checking out. The channel is a new project, but a noble one. Herrons helping burgeoning writers grow in a genre that many of them have loved during their entire lives, using a medium that helped him during one of the hardest times of his own.

The rest is here:
How One Man Overcame Blindness and Started an Audiobook ... - Gizmodo

The American Soybean Association submitted comments recently to both the U.S. Department of Agriculture and the U.S. Food and Drug Administration regarding regulations in response to advances in genetic engineering.

ASA included in comments to USDA, that biotechnology is an essential tool in farmers quest to produce enough food to meet the needs of 9.7 billion people by 2050, creating the need for a clear, science-based regulatory system in the U.S. as an example and standard for regulatory systems of biotechnology internationally.

While applauding USDAs efforts to reduce the burden on regulated entities, ASA expressed concern that aspects of the rule as proposed will increase the regulatory burden and stifle research and innovation.

Additionally, ASAs comments to FDA cheered USDAs proposal to exclude certain genome-editing techniques from requiring pre-market approvals because they are low risk and could be found in nature or achieved through traditional breeding methods.

ASA concluded its support saying, Technological advancements such as genome editing offer an additional tool to combat threats while also improving sustainability in production agriculture.

Read more here:
ASA provides input to USDA, FDA on advances in biotechnology - High Plains Journal

BBC News

Gait retraining considered for arthritis patients BBC News A walking technique which aims to help improve posture, balance and stability, could be used to improve the lives people with rheumatoid arthritis. Glasgow Caledonian University has received 18m to run trials for patients who have painful joints which ... and more »

Continued here:
Gait retraining considered for arthritis patients - BBC News

Arthritis is the pits. We all know that. I knew that when I was in my 20s, but I didnt give it a second thought. I was more interested in, shall we say, other things.

But now that Im in my 70s, I think about arthritis every morning. It wakes me up before my alarm rings. The ski injuries, the trekking-in-the-Himalayas injuries, the just plain Im old injuries have taken their toll.

Treatment for arthritis has improved dramatically. My mom used aspirin thats all they had. Then came Tylenol, much safer but not pristine. It wasnt until the late 80s that we realized taking too much acetaminophen, especially with booze, caused liver failure. (Side note: The safe dose is 4,000 milligrams a day; if you drink two drinks or more per day, then drop that to 2,000 milligrams a day.)

But for many, Tylenol is not that effective. Enter anti-inflammatories non-steroidal anti-inflammatory drugs, or NSAIDs. They are stronger for sure, better but not riskier. Still, side effects of NSAIDs may include gastrointestinal bleeds from your stomach, increased heart attack risk for those so prone, especially if youve had one before, and kidney disease. So we doctors have been moving away from these.

So whats a guy to do? The answer may be chondroitin sulfate.

Now, let me tell you, Ive been skeptical about this. I havent seen enough evidence to show that it does something. But a recent study from the Annals of Rheumatic Diseases is very encouraging. It shows chondroitin sulfate is as capable of treating arthritis as Celebrex, the safest effective anti-inflammatory around.

It was a double-blind study of 600 patients, all with symptomatic osteoarthritis the arthritis of old age. They were divided into three groups.

One group took 800 milligrams of pharmaceutical-grade chondroitin sulfate (well talk a bit later about what I mean by pharmaceutical grade). The other group took 200 milligrams of Celebrex. And the third group took dummy tablets.

At one month, three months and six months, everyone was asked about their pain, joint function and how they felt and functioned. At one month, the Celebrex group was in front. Good response and quick action. But at three months and six months, that advantage had disappeared. The chondroitin group did just as well.

This is good news. Taking this might be your answer to morning pain.

So which chondroitin sulfate product should you buy? Thats where the pharmaceutical grade comes in, and its a problem. Why? Because the Food and Drug Administration regulates them the same way it does cosmetics with a light hand. The label may say 800 milligrams, but the stuff inside may be much less.

My spin: I would go one of two ways with this. Consider the store brand chondroitin sulfate as big companies want to make sure they are selling a reliable product. Or go to my favorite go-to website http://www.consumerlab.com.

It costs money to join because they dont have advertising, but you get what you pay for. They test every brand they talk about and they tell you how much per milligram youre paying.

For me this is a great benefit because I want the right dose for the cheapest price. I highly recommend it. Stay well.

This column provides general health information and is not specific advice intended for particular individual(s). It is not a professional medical opinion or diagnosis. Always consult your personal health care provider about concerns. No ongoing relationship of any sort (including but not limited to any form of professional relationship) is implied or offered by Dr. Paster to people submitting questions.

Link:
Dr. Zorba Paster: Try chondroitin sulfate for arthritis pain - Madison.com

the Irish News

Anne Hailes: Practical advice for those living with arthritis - The Irish ... the Irish News THAT old saying 'There's always someone worse off than yourself' comes to mind when you suffer aches and pains, sleepless nights or a broken heart but your ... How to battle arthritis - Ahmedabad MirrorAhmedabad Mirror Early signals of knee arthritis | The Daily StarThe Daily Star 4 Steps To Reduce Arthritis Pain And Increase Mobility ...Information Nigeria all 4 news articles »

Continue reading here:
Anne Hailes: Practical advice for those living with arthritis - The Irish ... - the Irish News

Sessions & Tracks

Track 1: Advancements in Biotechnology

Biotechnology is an ever emerging field in which biological processes, organisms, cells and cellular components are exploited to develop novel expertise. Over the past two decades there have been revolutionary biotech innovations which helped the mankind. New tools and products developed by biotechnologists are expedient in research, agriculture, industry and the clinic.

Recent advancements in the field of biotechnology will underpin our economy and provide solutions to intractable problems of human and animal diseases, climate change, fuel alternatives, food security as well as improving our quality of life.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major | current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 2: Agriculture Biotechnology

Agriculture biotechnology or green biotechnology encompasses the use of scientific tools and techniques to understand and transform genetic make-up of living organisms such as plants, animals and microorganisms. The technology offers more precise improvements in crops and livestock and thus increases agricultural productivity. It has greater economic and social impacts as safe and sufficient food supply grown in a responsible method is essential for humanity.

Some of the applications include raising and stabilizing yields using plant breeding; to improve resistance to pests, diseases and abiotic stresses such as drought and cold; and to enrich the nutritional content of foods. Biotechnology is being used to develop low-cost disease-free planting materials for crops such as cassava, banana and potato and is creating new tools for the diagnosis and treatment of plant and animal diseases and for the measurement and conservation of genetic resources.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 3: Animal Biotechnology

Animal biotechnology is the practice of science and engineering to transform living organisms. Some of the examples include creating transgenic animals, generate specific inactivated gene using gene knockout technology and producing just about identical animals by cloning. It focuses on improving animal health and its welfare and thus increasing its productivity. Selective breeding and genetic engineering aids the animals in providing resistance to diseases and prevent injury.

Animal feeds and feeding practices are being altered by biotechnology to improve animal nutrition and to reduce environmental waste. Biotechnology is used in disease diagnostics and for the production of vaccines against animal diseases.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 4: Environmental Biotechnology

Environmental biotechnology is a system of science and engineering knowledge used in prevention, treatment and monitoring of environmental pollution through bio-treatment, bio-remediation of polluted environments, and bio-monitoring of environmental and its treatment processes. The process has been shown to play a substantial role inmaintainingzero waste agricultureand most significantly through the operation of over 15 millionbiogas digestersworldwide.

The main application of this system is the biodegradation/detoxication of hazardous substances in industrial waste. Some of the biotechnological agents used include bacteria, algae, fungi and protozoa.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 5: Food Biotechnology

Biotechnology has an extensive history in food production and processing. Food biotechnology involves the use of various techniques such as genetic engineering to improve productivity in food production and processing. This technology enables to produce new products with desirable characteristics such as leaner meat and nutritional rich foods.

Through newer biotechnology and genetic engineering techniques such as recombinant DNA (rDNA), researchers can move one gene, with the preferred specific traits, from one organism to another and omit the undesirable traits. This facilitates food producers to obtain animal and crop improvements in a much more precise, controlled and predictable manner.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 6: Industrial and Microbial Biotechnology

Industrial biotechnology, also known as white biotechnology in Europe, is one of the promising approaches that enable in averting pollution, conserve resources and thus cost reduction. The technology uses living cells and components of cells such as enzymes to yield industrially useful products in various sectors such as chemicals, bio-fuels, food etc. Microbial biotechnology implicates the manipulation of microorganisms at the gene and molecular level to yield useful products.

The above said biotechnology procedure enables to use renewable raw materials and can contribute to lowering greenhouse gas emissions and stirring away from a petrochemical-based economy.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 7: Marine Biotechnology

Marine biotechnology, also called as blue biotechnology, is defined as the application of biotechnology principles in marine resources to derive new cancer treatments for marine organisms. Marinebiotechnologyhas focused largely onmarine biomolecules, especiallyproteins, which may have uses in medicine or engineering. Marine environments are the home to many exotic biological materials that may stimulatebiomimetic materials.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 8: Nano Biotechnology

Application of nanotechnology in biological systems is known as nano-biotechnology. This is a newer technological approach to imagine and create newer systems that can be used for biological research. Biologically inspired nanotechnology uses biological systems as the reference for technologies which have not been created yet.

Nano-biotechnology is assisting modernmedicineevolve from treatingsymptomsto generatingcuresand regeneratingbiological tissues. Some of the applications of nano-biotechnology include stem cell treatments, growing uterus outside the body and then placed inside in animals and developing fluorescence polymers.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 9: Plant Biotechnology

Plant biotechnology applies scientific tools and techniques that accustom plants for precise purposes by cross-breeding, prolonging their growing seasons, adjusting height, color and texture and several other mechanisms. It can also be applied to exchange plant genes to produce novel genetic combinations and superior hybrid species.

Applications of plant biotechnology include biochemical production, rapid clonal multiplication, production of hybrid plants, genetic modification in plants etc.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 10: Medical Biotechnology

Medical biotechnology, also called as red biotechnology, involves the use of living cells and cell materials to create pharmaceutical and diagnostic products which helps to treat and prevent human diseases. The principles of medical biotechnology are applied in pharmacology, gene therapy, stem cells and tissue engineering.

The application of biotechnology to basic science has empowered wider knowledge and understanding ofbiology. As a result of our development in scientific knowledge of normal and disease biology, we could able to develop newer medicines to treat previously untreatable diseases.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 11: Pharmaceutical Biotechnology

Pharmaceutical biotechnology involves the application of principles of biotechnology in the development of drugs. Techniques such as recombinant DNA are used to design more effective drugs. Biotechnology has added to the discovery and manufacturing of traditionalsmall moleculepharmaceutical drugsas well as drugs. Modern biotechnology allows manufacturing existing medicines relatively easy and less economical.

Modern biotechnology facilitates its use in pharmaceutical drugdiscovery, production and development,pharmacogenomics and genetic screening.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 12: Bioengineering and Biotechnology

Bioengineering refers to the usage of molecular biology to study advance applications and to create biotechnology. It extends to the creation of artificial organs and develops genetically modified organisms. It employs knowledge from pure and applied sciences such as mass and heat transfer, kinetics, biocatalysts, biomechanics, bioinformatics etc.

Bioengineering is applied in the design of medical devices, diagnostic equipment, biocompatible materials, renewable bioenergy and other areas that progress the living standards of societies.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 13: Bio-products and Bioenergy

Bio-products are biologically derived products such as chemicals, materials and energy from renewable resources. There are two types of bio-products namely conventional bio-products and emerging bio-products. Examples of conventional bio-products are pulp and paper, building materials and forest products whereas emerging bio-products include bioenergy, biofuels, bio-chemicals, bio-plastics etc.

Bioenergy is a renewable energy from materials derived from biological resources. It is a single largest renewable energy source providing 10% of worlds primary energy supply.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 14: Bioinformatics

Bioinformatics is a branch of biotechnology that involves use of computer applications such as applied math and statistics to analyze and interpret biological data. It helps in organizing the large-scale information and analysis of biological queries using mathematical and statistical techniques. It is used in the identification of candidate genes and nucleotides which helps in better understanding of genetic basis of disease and its properties.

Bioinformatics is useful in areas such asfunctional genomics,structural genomics, andproteomics, and acts as a key constituent in the biotechnology and pharmaceutical sector.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Track 15: Biotech Industry

Biotechnology industry harnesses cellular and bio-molecular processes to develop technologies and products that help improve our lives and the health of our planet. Modern biotechnology provides breakthrough products and technologies to combat incapacitating and infrequent diseases, reduce our environmental footprint, feed the hungry, use less energy, and have safer, cleaner and more efficient industrial manufacturing processes.

The biotech industry broadly segments into the medical and agricultural markets. Although enterprising biotechnology is also being applied to other exciting areas like industrial production of chemicals, andbioremediation, the use in these areas is still specialized and limited. Biotechnology introduced a whole new approach to drug development that did not easily integrate into the chemically-focused approach most of the established pharmaceutical companies were using.

Related:Biotechnology Conferences|Biotechnology Meetings|Biotechnology Conventions| biotechnology| biotech marketing| what does a biotechnologist do|biotechnology major|current events biotechnology

15th World Congress on Biotechnology and Biotech Industries Meet, March 20-22, 2017 at Rome, Italy; Biotechnology 2017, August 21-23, 2017 at Chicago, USA; 17thEuro Biotechnology Congress, September 25-27, 2017 at Berlin, Germany; Global Biotechnology Congress, Oct 9-11, 2017 at Auckland, New Zealand; 15thInternational Pharmaceutical Microbiology and Biotechnology Conference, June 21-23, 2017 at London, UK; 2ndInternational Conference on Bioscience and Biotechnology, March 9-10, 2017 at Colombo, Sri Lanka; BIO World Congress on Industrial Biotechnology, July 23-26, 2017 at Montreal, Canada; BioTech 2017, June 13-17 at Prague, Czech Republic; European Federation of Biotechnology; Society for Industrial Microbiology and Biotechnology (SIMB); The Biotech Research Society; Biotechnology and Biological Sciences Research Council (BBSRC); Australias Biotechnology Organization (AusBiotech); New Zealand Biotechnology (NZBIO); Biotechnology Innovation Organization (BIO).

Scope and Importance of Biotechnology

Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, medicine, technology and other fields requiring bio-products. Modern use similar term includes genetic engineering as well as cell and tissue culture technologies. It is the integrated use of molecular biology, biochemistry and microbiology to achieve technological application of the capabilities of biological agents. Biotechnology is emerged as a science with immense potential for human welfare ranging from food processing, human health to environment protection. The field of biotechnology is constantly advancing. From finding ways to slow down the process of food spoilage, advancements in genetic engineering, to adapting organisms to clean up contaminated environments, new applications and biotechnological inventions are continuously being developed to help improve our world.

Modern biotechnology applies not only modern genetics but also advances in other sciences. However, there is a third revolution that is just emerging, which is nanotechnology. The development of techniques to visualize and manipulate atoms individually or in small clusters is opening the way to an ever-finer analysis of living systems. Nano-scale techniques are now beginning to play substantial role in the application of biotechnology.

World renowned experts and intellectuals agree that biotechnological innovation is the foundation-stone of our future, and a game changer. It is anticipated that it will underpin our economy and provide solutions to intractable problems of human and animal diseases, climate change, fuel alternatives, food security as well as improving our quality of life.

Biotechnology in Australia

The Australian biotechnology industry is one of the largest in the world. Despite the challenges of the global economy and the degree of difficulty in building a biotechnology and life sciences sector from scratch, Australia is doing very well by any comparative measure, with an impressive return on investment from a maturing stock of quality companies. Australian biotechnology boasts a raft of success stories and a world-class industry. Since its emergence in the early to mid-nineties, the biotechnology industry in Australia has achieved a great deal.

Australias comparative advantage comes from its world-class science and medical research, its capacity for international partnerships, cost effectiveness, and a transparent and effective regulatory system. Jobs of the future will be found in the biotech and pharmaceuticals sector, and the medical technology sector. In addition, there are many thousands of direct jobs in the agricultural and industrial biotechnology sectors and indirect jobs in dependent areas such as clinical trial teams, high-tech manufacturing, medical research and supplies to the medical technology sector and in services such as those provided by patent attorneys. Innovative industries provide high-skilled jobs with long-term prospects.

The Research & Development (R&D) Tax Incentive has been a long-established source of funding and support for businesses in the research, development and early developmental commercialization phases. The policy driver behind the R&D Tax Incentive is to encourage more companies to engage in R&D in Australia. And its working: a number of companies have publically stated that they have set up in Australia because of the support provided by the R&D Tax Incentive.

Australian state governments are developing and implementing independent regional initiatives. Each has strong medical research programs, some having specialist expertise in areas including tropical medicine, bio-discovery, regenerative medicine, bioremediation, agricultural/industrial biotech and medical devices. Australian life sciences companies have attracted well over $2 billion in deal flow over the last 18 months. Global recognition of the sectors quality was reflected in major deals, including Novartis acquisition of Spinifex Pharmaceuticals for as much as AU$1 billion and AstraZenecas licensing agreement with Starpharma that could deliver over half a billion (AU) dollars.

List of Major Universities in Melbourne and Australia

Read the rest here:
Biotechnology Conferences - Asia Pacific Biotech Congress

Arthritis affects more than 10 million people and it takes over the lives of sufferers. Heres how to cope with, or avoid the condition

Arthritis affects more than 10 million people and it takes over the lives of sufferers.

The crippling condition can cause severe mobility problems, make sleeping impossible and turn basic tasks into a mission.

But instead of relying on anti-inflammatories and painkillers, which have been linked to stomach and heart issues, try these alternatives.

And they could even stop you from developing the condition in the first place.

Tuck into pomegranates

Chemicals found in the exotic fruits can protect against osteoarthritis, the most common form of arthritis.

Called phytochemicals, they help prevent damage to cartilage cells, which keeps bones healthy.

Pomegranate seeds are also full of punicic acid, which has powerful antioxidant properties and could reduce joint inflammation.

Mediterranean diet plan

Eating more fruit, vegetables, beans, whole grains, olive oil and fatty fish may help tackle the disease and increase mobility.

The first study into the link between a Mediterranean diet and osteoarthritis recently found that eating more of these ingredients over a 16-week period helped reduce inflammation and maintain bone health.

Run by the charity organisation, Arthritis Action, the research saw the inflammatory blood biomarker of participants drop by almost half, while a cartilage degeneration dropped eight per cent. The experts also recommended cutting down on red meat.

Tai chi

If you are looking for more of a relaxed exercise regime, try tai chi. The Chinese practice has been linked to reduced pain, fatigue and stiffness, plus improved mobility in people with osteoarthritis.

The slow breathing and gentle movements boost muscle strength and balance. After six weeks, participants in a University of Miami study were able to walk faster and further.

Go for a jog

It is important to keep muscles and joints moving, even if you do not have arthritis.

Moderate exercise has even been found to help prevent osteoarthritis in the knees and hips physical activity helps lubricate the joints and maintain cartilage elasticity.

While running had previously been thought to be bad for joints, a study recently found that regular jogs are good news for the knees and hips and can cut your osteoarthritis risk. But researchers for the study, published in the Journal of Orthopaedic and Sports Physical Therapy, say overdoing it could do more harm than good.

Get pedalling

Stationary cycling, otherwise known as spinning, is good for the knees. Researchers at Northern Illinois University found it is the best form of exercise to get people with mild-to-moderate symptoms back on their feet.

Magnet magic

Pulsed electromagnetic field therapy is providing an alternative to antiinflammatories and painkiller medication. The clever tech is in a wearable device and involves an electrically charged magnet, which delivers energy to the painful area. Patients with osteoarthritis who used the gadget for 12 hours a day over one month saw their pain greatly reduced, according to a study in Rheumatology journal. And some even came off painkillers completely.

Visit link:
How to battle arthritis - Mumbai Mirror

Rheumatoid arthritis is one of the most common types of arthritis to affect women. It can occur in all stages of life, especially in the later years. Scientists are still trying to understand the reasons behind the ailment, along with ways to cure it.

Trying to prevent rheumatoid arthritis isnt always easy. In fact, there is very little that you can do to stop it from happening completely. You can, however, take steps to slow down the progression and avoid it from taking over your life.

The diet is one of the most common ways to help prevent rheumatoid arthritis from becoming a major issue in life. Its food, after all, that can lead to inflammation within the body. This causes inflammation in the joints, leading to pain and stiffness within them.

So, heres a look at 12 of the best snacks to eat. They will help to prevent arthritis from occurring and getting worse over time.

Opt for Oily Fish for a Small and Filling Snack

When we think about snacks, we often reach for small bars of chocolate or pieces of fruit. While some snacks are powerful, its time to reach for more protein. This is especially the case when it comes to oily fish. Opt for some tuna, salmon, or even mackerel for your next healthy snack.

The fishes are full of omega 3 fatty acids. These fatty acids have anti-inflammatory properties, which help to keep your bodys natural immune system response to a minimum. While inflammation is part of the healing process, it occurs when it shouldnt. It is especially problematic in the gut, but it can also lead to problems within the joints.

Fish is also good for brain health, making it one of those snacks that you want to eat before an exam.

Go here to read the rest:
12 Best Healthy Snacks That Help Prevent Rheumatoid Arthritis - South Florida Reporter

eyeSight takes its machine learning capabilities that can detect and recognize people and gestures to revolutionize the off-the-shelf security camera market

HERZLIYA, ISRAEL--(Marketwired - Jun 22, 2017) - eyeSight Technologies, a leader in advanced embedded computer vision and machine learning, today announces the expansion of its smart sensing offering to home security camera manufacturers and smart home system developers. Using a combination of advanced embedded computer vision and deep learning modules, eyeSight's complex software can transform any simple Wi-Fi connected IP camera into a smart AI guard.

Adding AI to standard off-the-shelf home security cameras is a game changer in the home security/smart home space as camera manufacturers can now add intelligent-sensing capabilities to their existing standard security camera offering -- no expensive sensors or hardware changes are required.

eyeSight's computer vision technology was designed for a wide range of sensing applications, from active interactions such as touch-free gesture recognition, to passive sensing such as detection of user presence and their actions. Security cameras with eyeSight's software will have the following capabilities that add a layer of intelligent-safety and comfort to the home:

"Our state-of-the-art technology offers manufacturers and smart home providers an amazing upgrade to their products with a simple software update, moving them from providers of a standard security cameras to smart AI guards for the home," said Gideon Shmuel, CEO of eyeSight. "We have years of experience in this field, so we know how to deliver smart, intelligent sensing capabilities to even the simplest of cameras through our proprietary software solutions."

To learn more about eyeSight Technologies, visit http://www.eyesight-tech.com.

About eyeSight Technologies eyeSight is the leading provider of embedded computer vision and deep learning solutions, bringing user awareness and gesture recognition technologies to a variety of devices and industries. The company's technology improves daily life interactions with the home, the car, and other consumer electronics with simplified user interactions that are intelligent and personalized. eyeSight's technology was designed for a wide range of applications, from active interactions with gesture recognition and finger tracking, to passive user detection and face analysis, delivering customized experiences based on user features and actions. For more information, visit http://www.eyesight-tech.com.

Read the original post:
eyeSight Technologies Expands Computer Vision Expertise to Transform any Wi-Fi Connected Home Security Camera ... - Marketwired (press release)

WASHINGTON -- An experimental drug is showing promise against an untreatable eye disease that blinds older adults and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.

Age-related macular degeneration, or AMD, is the leading cause of vision loss among seniors, gradually eroding crucial central vision. There are different forms but more than 5 million people worldwide, and a million in the U.S., have an advanced type of so-called "dry" macular degeneration that has no treatment. At first patients may notice blurriness when they look straight ahead. Eventually many develop blank spots, becoming legally blind.

"These are seniors who are entering their golden years and now they've lost the ability to read, watch television, see their loved ones," said Dr. Rahul Khurana, a retina specialist and spokesman for the American Academy of Ophthalmology.

The experimental drug, lampalizumab, aims to slow the destruction of light-sensing cells in the retina, creeping lesions that characterize the stage of dry AMD called "geographic atrophy." When those cells die, they can't grow back the vision loss is irreversible.

In an 18-month study of 129 patients, monthly eye injections of the drug modestly slowed worsening of the disease when compared with patients given dummy shots. What's exciting for scientists came next, when researchers from drugmaker Genentech Inc. took a closer look at exactly who was being helped.

It turns out that nearly 6 in 10 of the study's participants carry a gene variation that makes part of the immune system go awry - a genetic flaw already known to increase the risk of getting macular degeneration in the first place.

Those are the only patients who appeared to benefit from the drug; they had 44 percent less eye damage than the untreated patients, the Genentech team reported Wednesday in the journal Science Translational Medicine. While the study is too small to prove if lampalizumab really helps maintain vision, that's a bigger difference than the overall results suggested.

One arm of the immune system, the complement pathway, helps fight infections by attracting immune cells to attack bacteria.

Normally, there's a barrier that keeps such cells away from the retina. But that barrier can break down with age, opening sensitive eye cells to harm from the spillover, explained Genentech immunologist Menno van Lookeren Campagne.

Now for the gene connection: Previous studies have linked macular degeneration to gene variations that remove some of that pathway's natural brakes, so it can become too active.

Play Video

A Boston man who lost his sight to the eye disease retinitis pigmentosa is getting a new look at the world with bionic eye technology. Paula Ebbe...

The hypothesis: Genentech's drug, lampalizumab, essentially offers a backup method for tamping down the immune reaction. An antibody, it works by inhibiting a particular enzyme named factor D that helps power the immune pathway.

"We try to reinsert the braking ability," said study lead author Brian Yaspan, a Genentech senior scientist.

Wednesday's study detected no safety concerns, clearing the way for Genentech and its parent company Roche to open two large-scale studies that aim to prove if the drug works. Results are expected later this year.

The current research sheds light on how that long-suspected immune culprit might be working, and is "the first suggestion that there may be a treatment for geographic atrophy coming up in the future," said National Eye Institute retina specialist Dr. Wai Wong, who wasn't involved in the study.

"It's a very, very exciting study," said Khurana, the ophthalmologist association's spokesman, who also wasn't part of the research. "From the basic science perspective, it makes a lot of sense."

Macular degeneration tends to occur after age 60, but it sometimes strikes earlier. According to the National Eye Institute, it's less common in people who exercise regularly, avoid smoking, and eat a diet high in green leafy vegetables and fish.

Symptoms often aren't noticeable early on. But several eye tests can detect signs of macular degeneration, including a dilated eye exam and a tool called an Amsler grid with straight lines that may look wavy if the macula, the center of the retina, is harmed.

Macular degeneration patients often are advised to take certain vitamin combinations that may help stave off advanced disease. And it's important for patients to know what type they have. While there's no treatment for the advanced dry form, the "wet" form occurs when leaky blood vessels grow under the retina and there are several therapies that can help those patients preserve vision.

Visit link:
Experimental drug offers hope to seniors with vision-robbing disease - CBS News

WebMD Medical Reference

Claims you can improve your vision with simple eye exercises and without the need for glasses, contact lenses, drugs, or surgery have been around for decades.

It's an appealing idea but there is no research to back it up, and most experts consider the claims to be bogus and some of the techniques dangerous.

Natural vision correction is an alternative therapy and most practitioners base their approach on the Bates Method.

This was pioneered almost 100 years ago (1919) by Dr William Bates, an ophthalmologist and author of 'The Bates Method for Better Eyesight Without Glasses'. He believed the cause of short-sightedness, long-sightedness, and other refractive errors was tension, and that relaxing the eyes would allow them to function normally.

The Bates Method believes that vision is affected by the mind, body, emotions, and reaction to stress. The emphasis is on using the eyes and mind in a relaxed and natural way. Those who use it are encouraged to do eye exercises, including palming (covering closed eyes with your palms) and sunning (guiding a light source directly onto closed eyes), and to do without their glasses.

Followers of Bates claim all the conditions normally corrected by glasses can be eliminated, and some even say the method can help or eliminate serious eye diseases, such as cataracts and glaucoma.

Teachers of the Bates Method charge in the range of 30 - 75 an hour.

Others believers in natural vision correction use eye exercises, eye patches, eye massages, and nutritional supplements, but reject some of Bates ideas, like sunning, and are also happy to work alongside conventional and licensed optometrists (people who are not doctors, but are trained to evaluate vision and the health of the eye, as well as to prescribe glasses and contact lenses) or ophthalmologists (medically trained doctors who have specialist training in conditions related to the eye).

Practitioners of natural vision correction may have what appear to be convincing anecdotal testimonials from patients, but the Bates Method is not taught in accredited schools of optometry and is not recognised by professional ophthalmology or optometry organisations.

The UK based Association of Optometrists (AOP), with more than 17,000 members, does not support the use of the Bates Method and would always recommend that patients seek professional advice. It says it is unaware of any scientific evidence to suggest that the Bates Method is effective, and goes further by saying solarisation or sunning, is dangerous and could lead to retinal damage in the form of a solar retinopathy.

In 2002, the American Academy of Ophthalmology (AAO) published its opinion on visual training programmes to improve eyesight. It found no evidence that they had any effect on the progression of short-sightedness, or that it improved visual function for patients with long-sightedness or astigmatism, or that it improved vision lost because of diseases, including age-related macular degeneration, glaucoma or diabetic retinopathy.

It concluded the only risk of visual training was financial, and that glasses and contact lenses may be a nuisance, but they work.

Read the original:
Natural vision correction & The Bates Method - WebMD.Boots.com